Loading...
VTS is not a good buy right now. Price is pushing into near-term resistance with an overbought short-term momentum setup, options flow is heavily put-skewed by volume, and fundamentals recently deteriorated (losses + margin compression). Given no proprietary buy signals today and elevated insider selling, the risk/reward favors avoiding new buys (or trimming) at current levels.
Trend/Momentum: MACD histogram is positive (0.208) and expanding, which supports an upswing, but RSI(6) at ~79 is effectively overbought and increases pullback risk. Structure/Levels: Price ~20.76 is sitting just below R1 (20.819) and below R2 (21.333). Nearby pivot support is ~19.986, then S1 ~19.153. With moving averages converging, the stock is near an inflection point; a failure at ~20.82–21.33 would likely mean a retrace toward ~20.0. Pattern-based forward view (provided): next day ~-0.66%, next week ~-2.1%, next month ~+0.25% (mixed-to-slightly negative near term).
Intellectia Proprietary Trading Signals

was +15.72% YoY.
on 2026-02-26 after hours (Est. EPS 0.
could act as a catalyst if profitability rebounds.
while price is pressing into resistance (R1 ~20.82 / R2 ~21.33), raising pullback risk.
Latest reported quarter: 2025/Q3. Growth: Revenue rose to 67.44M (+15.72% YoY). Profitability: Net income fell to -1.31M (-107.52% YoY) and EPS to -0.03 (-105.66% YoY), indicating a move into losses. Margins: Gross margin dropped to 12.65% (-55.08% YoY), a significant deterioration that weakens the fundamental backdrop despite top-line growth.
No analyst rating or price target change data was provided, so a recent trend summary cannot be confirmed from this dataset. From the available facts, Wall Street-style pros would point to revenue growth and a potential earnings catalyst; cons would focus on the profitability/margin deterioration and heavy insider selling.